We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Rosemary Oil (Rosmarinus officinalis, topical)
A plant essential oil applied (diluted) to the scalp for hair growth — a topical cosmetic, NOT ingested. Rosemary oil became popular as a 'natural minoxidil' after a single 6-month randomized trial (100 people) found it matched 2% minoxidil for hair-count gain in androgenetic alopecia, with less scalp itching. The honest framing: that one open-design trial carries almost the entire human case. A plausible mechanism exists (rosemary inhibits the DHT-making enzyme 5-alpha-reductase in lab/animal studies), but the often-cited 'aromatherapy' hair trial used a four-oil mixture (not rosemary alone) for a different condition, and a 2023 systematic review rated essential-oil hair evidence sparse and low-quality. As an essential oil it must be diluted to avoid scalp irritation. This is a cosmetic appearance use, not a proven medical treatment.
Topical cosmetic ingredient — not a dietary supplement
Rosemary Oil (topical) is a topical cosmetic ingredient, not a supplement you take internally and not a drug. It is sold legally in skincare products to affect the appearance of skin (such as wrinkles). The evidence below comes mostly from small, often industry-funded studies of topical application, so treat the effect sizes cautiously. This page is for transparency and education, not a recommendation.
What the evidence says
Most Rosemary Oil (topical) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from medium-quality randomised trials published 1998–2024 with a typical study size of 100 participants.
Based on 7 studies · 5 RCTs · 186 total participants
Confidence
Moderate confidenceBy outcome
One 6-month randomized trial (n=100) found topical rosemary oil matched minoxidil 2% for hair count in androgenetic alopecia, backed by a plausible 5-alpha-reductase mechanism — but the entire human case rests on that single open-design trial with no placebo replication, and the other 'rosemary' hair trial was a multi-oil mixture for a different condition.
2 trials ongoing or recruiting · 5 completed on ClinicalTrials.gov
1 of the completed trials have posted results
Registered trials show research momentum for Rosemary Oil (topical), not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Aug 2026
Rosemary oil is the essential oil of Rosmarinus officinalis (now Salvia rosmarinus), used topically — diluted in a carrier oil or formulation and massaged into the scalp — as a popular 'natural' alternative to minoxidil for pattern hair loss. It is a TOPICAL cosmetic, not an ingested supplement.
The interest is real but the evidence is thin and rests largely on one study.
In a 6-month randomized comparative trial (Panahi et al., 2015; 100 patients with androgenetic alopecia), rosemary oil and minoxidil 2% produced comparable, statistically significant increases in hair count, with no significant difference between groups — and scalp itching was actually more frequent in the minoxidil group.
Notably, neither group improved at 3 months; the benefit only emerged by 6 months.
Mechanistically, rosemary has a plausible anti-androgenic action: a mouse/in-vitro study (Murata et al., 2013) found topical rosemary leaf extract restored testosterone-suppressed hair regrowth and inhibited the enzyme 5-alpha-reductase (which converts testosterone to the hair-miniaturising hormone DHT) by 82-95% at the concentrations tested.
Here are the honest caveats, and they are significant. The human case is essentially that single open-design comparative trial — there is no placebo-controlled replication.
The frequently-cited 'aromatherapy' hair trial (Hay et al., 1998) used a MIXTURE of thyme, rosemary, lavender, and cedarwood oils in carrier oils for alopecia areata (an autoimmune patchy hair loss, different from pattern baldness), so its benefit cannot be attributed to rosemary alone.
A 2023 systematic review (Tkachenko et al.) of complementary therapies for alopecia areata listed essential-oil aromatherapy among those with the 'best' evidence but explicitly cautioned that inconsistent, poorly reported methodology and nonstandardized outcomes limit any firm conclusion.
As an essential oil, rosemary must be diluted before scalp use, as undiluted application can cause irritation or contact dermatitis.
None of this is a health claim: rosemary oil is a lawful cosmetic whose documented benefit is a possible, modest improvement in hair density in pattern hair loss, supported by one trial and mechanistic data — promising but far less proven than minoxidil.
It is listed under Beauty & Appearance so it is discoverable, but is sandboxed out of ingestible-supplement stacks and the schedule optimizer; it carries a cosmetic badge and a topical-only disclaimer.
In lab and animal studies, rosemary leaf extract inhibits testosterone 5-alpha-reductase — the enzyme that converts testosterone to DHT, the hormone that miniaturises hair follicles in pattern hair loss — by over 80% at the concentrations tested, and restored testosterone-suppressed hair regrowth in mice. This anti-androgenic action is the proposed basis for its hair effect.
Rosemary is a traditional circulatory stimulant with antioxidant constituents (e.g. carnosic acid). Improved local microcirculation and reduced oxidative stress around the follicle are proposed contributors, though these are mechanistic/traditional rationales rather than proven clinical drivers.
Topical essential oils have limited safety data in pregnancy and lactation; discuss use with a clinician and avoid ingestion entirely.
Use a low dilution and patch-test first; essential oils are a common cause of contact irritation.
Manage expectations — evidence is single-study; minoxidil has far stronger, FDA-approval-grade evidence for pattern hair loss.
Layering rosemary oil with other scalp actives or multiple essential oils can increase the chance of irritation; introduce one at a time. This is a tolerability/formulation consideration, not a systemic drug interaction — it is not ingested.
Tip: Always dilute in a carrier oil and patch-test before full scalp use; reduce frequency or stop if irritation occurs.
Tip: Discontinue if an allergic reaction develops; choose a lower concentration or fragrance-controlled product.
Rosemary Oil (topical) has an evidence score of 4/10 — emerging evidence based on 7 indexed studies. A plant essential oil applied (diluted) to the scalp for hair growth — a topical cosmetic, NOT ingested. Rosemary oil became popular as a 'natural minoxidil' after a single 6-month randomized trial (100 people) found it matched 2% minoxidil for hair-count gain in androgenetic alopecia, with less scalp itching. The honest framing: that one open-design trial carries almost the entire human case. A plausible mechanism exists (rosemary inhibits the DHT-making enzyme 5-alpha-reductase in lab/animal studies), but the often-cited 'aromatherapy' hair trial used a four-oil mixture (not rosemary alone) for a different condition, and a 2023 systematic review rated essential-oil hair evidence sparse and low-quality. As an essential oil it must be diluted to avoid scalp irritation. This is a cosmetic appearance use, not a proven medical treatment. Representative study: PMID 31870916.
The commonly studied dose of Rosemary Oil (topical) is Topical cosmetic only. Rosemary essential oil is diluted (commonly to roughly 1-3% in a carrier oil, or used in a formulated scalp product) and massaged into the scalp once daily or a few times weekly. The trial regimen applied it over 6 months. There is no oral, injectable, or systemic dose — it is not ingested. Always dilute and patch-test. This library does not provide an ingestion protocol.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Timing is flexible for Rosemary Oil (topical) — consistent daily use matters more than the time of day. Rosemary oil is a leave-on/scalp-massage topical with no meal-timing relationship; consistency of use over months matters more than time of day.
Rosemary Oil (topical) is generally well-tolerated and considered safe for most healthy adults at recommended doses. Reported side effects are uncommon and include scalp irritation or contact dermatitis, allergic sensitisation. Use caution if any of these apply to you: For topical (scalp/skin) use only — not for ingestion; Do not apply undiluted essential oil to the skin or scalp; Known allergy or sensitivity to rosemary or formulation components.
Centella Asiatica (Cica)
Mostly mechanism / observationalA viral 'cica' botanical applied to the skin for soothing, barrier repair, wound healing, and anti-aging — a topical cosmetic, not (in this context) the oral gotu kola supplement. Centella asiatica's active triterpenes (madecassoside, asiaticoside, asiatic/madecassic acid) stimulate collagen and calm inflammation. The honest framing: the best human evidence is for wound healing and post-procedure soothing; the anti-aging signal rests on a single small (n=20) trial that combined madecassoside with vitamin C, scar/stretch-mark evidence is weak, and much of the mechanism is in-vitro/animal. Contact allergy is uncommon but documented. A genuinely promising, well-tolerated soothing botanical with moderate, still-maturing evidence.
Tea Tree Oil (topical)
Mostly mechanism / observationalA plant essential oil applied to the skin for acne — the best-evidenced 'natural' acne topical, though that's a low bar. The honest framing: two small randomized trials back it. A classic 1990 RCT found 5% tea tree oil reduced acne lesions about as much as 5% benzoyl peroxide with fewer side effects (but slower to work), and a 2007 placebo-controlled RCT found 5% tea tree oil gel several times more effective than placebo. Its active terpinen-4-ol is genuinely antibacterial against the acne bacterium. But the evidence is small, dated, and rated low-quality by Cochrane; there's no large modern standardized trial, products vary widely in composition, and tea tree oil is a well-recognized cause of allergic contact dermatitis — especially as it oxidizes with age. A reasonable gentle option for mild acne, not a first-line treatment.
Bakuchiol
Mostly mechanism / observationalA plant-derived topical skincare active marketed as a gentler 'retinol alternative' — a leave-on cosmetic applied to the skin, NOT ingested. Bakuchiol is a meroterpene purified from the seeds of Psoralea corylifolia (babchi). Despite no structural resemblance to retinoids, gene-expression studies show it behaves like a functional retinol analogue, switching on collagen genes. The headline evidence is one good 12-week randomized, double-blind trial (44 people) in which bakuchiol matched retinol for reducing wrinkles and pigmentation while causing less stinging and scaling. The honest framing: that single 44-person study carries most of the weight. The rest of the human evidence is thin — small, often unblinded or uncontrolled trials, several testing bakuchiol only inside multi-ingredient products, and many industry-linked; a 2024 systematic review judged the body of evidence high-risk-of-bias and not poolable. These are cosmetic appearance outcomes, not health outcomes. (Note: purified topical bakuchiol is distinct from oral Psoralea corylifolia, which carries hepatotoxicity and phototoxic-furocoumarin concerns.)
Licorice Extract / Glabridin (topical)
Mostly mechanism / observationalA licorice-root botanical applied to the skin for brightening and soothing — a topical cosmetic, not the ingested licorice supplement. Its actives glabridin (a tyrosinase inhibitor) and liquiritin (which disperses melanin) plus anti-inflammatory compounds give it a coherent rationale for fading hyperpigmentation and calming redness. The honest framing: the human evidence is genuinely thin — one small split-face RCT of liquiritin cream for melasma, one comparative trial of a licorice-containing blend that nearly matched hydroquinone, and otherwise preclinical work. A gentle, plausible brightener whose isolated effect is poorly established and rests on small, dated, mostly combination studies.
Explore: Best supplements for Skin, Hair & Beauty
Reviewed by Dr. Baher Al Hakim · Last reviewed June 2026 · evidence from 7 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.